In the BioHarmony Drug Report Database

"Preview" Icon

Bendamustine

Belrapzo, Bendeka, Treanda (bendamustine) is a small molecule pharmaceutical. Bendamustine was first approved as Belrapzo on 2008-03-20. It is used to treat lymphoid leukemia and non-hodgkin lymphoma in the USA. Treanda’s patents are valid until 2033-03-15 (FDA).

 

Trade Name

 

Belrapzo, Bendeka, Treanda
 

Common Name

 

bendamustine
 

ChEMBL ID

 

CHEMBL487253
 

Indication

 

lymphoid leukemia, non-hodgkin lymphoma
 

Drug Class

 

Antineoplastics (chloroethylamine derivatives)

Image (chem structure or protein)

Bendamustine structure rendering